# US 2021/0069124 A1 · Zeaxanthin Formulations With Additional Ocular-Active Nutrients, For Protecting Eye Health And Treating Eye Disorders

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2021/0069124 A1
- Document ID: US20210069124A1
- Status: Published application
- Kind: A1
- Application number: 16/949,955
- Filed: 2020-11-20
- Published: 2021-03-11
- Earliest claimed: 2003-12-23
- Assignees: ZeaVision LLC
- Applicants: ZeaVision LLC
- Inventors: Dennis L. Gierhart
- Web page: https://patentgrep.com/patent/US20210069124A1

## CPC

- A61K 31/047: having two or more hydroxy groups, e.g. sorbitol
- A23L 33/105: Plant extracts, their artificial duplicates or their derivatives
- A23L 33/115: Fatty acids or derivatives thereof; Fats or oils
- A23L 33/15: Vitamins
- A61K 9/0048: {Eye, e.g. artificial tears}
- A61K 31/07: Retinol compounds, e.g. vitamin A (retinoic acids A61K31/203)
- A61P 27/00: Drugs for disorders of the senses
- A23V 2002/00: Food compositions, function of food ingredients or processes for food or foodstuffs
- A61K 9/0095: {Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches (A61K9/0007 takes precedence; eatable gels or foams A61K9/0056; oral mucosa adhesive forms A61K9/006)}
- A61K 9/20: Pills, tablets, {discs, rods (A61K9/0004, A61K9/0007, A61K9/0056, A61K9/0065 take precedence; for reconstitution of a drink A61K9/0095)}
- A61K 9/48: Preparations in capsules, e.g. of gelatin, of chocolate {(A61K9/0004 takes precedence; bite capsules A61K9/0056)}
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A23L: FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF (preservation thereof A23B)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A23V: INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION

## Abstract

Oral formulations for promoting eye health, and in particular for preventing or treating macular degeneration, are disclosed, containing zeaxanthin, a carotenoid pigment, and at least two or more additional ocular-active nutrients selected from lipoic acid, omega-3 fatty acids, plant-derived compounds such as flavonoids, anthocyanins, or polyphenolics, taurine, carnitine, Coenzyme-Q10, carnosine, and nutrients that stimulate the production of glutathione. Processes are disclosed for identifying ocular-active nutrients that will interact in a synergistic and potentiating manner with zeaxanthin, to provide better and more effective protection, for eye health, than can be provided by zeaxanthin alone. Additional optional agents include zinc, vitamin E, and vitamin C.

## Claims

### Claim at position 1

1-4. (canceled)

### Claim 5

A nutritional supplement for eye health, comprising:
a capsule or tablet for oral ingestion that includes a composition comprising
(a) at least 0.5 mg of zeaxanthin, the zeaxanthin being present in the 3R-3R′ stereoisomer form and is substantially free of meso-zeaxanthin stereoisomers,
(b) zinc in an amount that does not exceed 40 mg,
(c) vitamin E, and
(d) vitamin C.

### Claim 6 (depends on 5)

The nutritional supplement of claim 5, wherein the composition further includes omega-3 fatty acids.

### Claim 7 (depends on 6)

The nutritional supplement of claim 6, wherein the composition further includes a lipoic acid

### Claim 8 (depends on 7)

The nutritional supplement of claim 7, wherein the composition further includes lutein.

### Claim 9 (depends on 5)

The nutritional supplement of claim 5, wherein the composition further includes lutein.

### Claim 10 (depends on 9)

The nutritional supplement of claim 9, wherein the composition further includes omega-3 fatty acids

### Claim 11 (depends on 9)

The nutritional supplement of claim 9, wherein the composition further includes mixed tocopherols.

### Claim 12 (depends on 5)

The nutritional supplement of claim 5, wherein vitamin C is in the form of ascorbic acid.

### Claim 13 (depends on 5)

The nutritional supplement of claim 5, wherein the capsule or table provides a daily dosage of the ingredients to the user that is released over a span of at least 3 hours following the oral ingestion.

### Claim 14 (depends on 5)

The nutritional supplement of claim 5, wherein zeaxanthin is present in an amount of at least 10 milligrams.

### Claim 15 (depends on 5)

The nutritional supplement of claim 5, wherein the composition contains an oily carrier material to enhance the uptake and bioavailability of the zeaxanthin.

### Claim 16 (depends on 5)

The nutritional supplement of claim 5, wherein the composition further comprises at least one of taurine, carnitine and carnosine.

### Claim 17

A nutritional supplement for eye health, comprising:
a capsule for oral ingestion that includes a composition comprising
(a) an oily carrier material
(b) at least 0.5 mg of zeaxanthin, the zeaxanthin being present in the 3R-3R′ stereoisomer form and is substantially free of meso-zeaxanthin stereoisomers,
(b) zinc in an amount that does not exceed 40 mg,
(c) vitamin E, and
(d) vitamin C in the form of ascorbic acid.

### Claim 18 (depends on 17)

The nutritional supplement of claim 17, wherein the composition further includes omega-3 fatty acids.

### Claim 19 (depends on 18)

The nutritional supplement of claim 18, wherein the omega-3 fatty acids include docosa-hexaenoic acid (DHA) and eicosa-pentaenoic acid (EPA).

### Claim 20 (depends on 17)

The nutritional supplement of claim 17, wherein the composition further includes a lipoic acid.

### Claim 21 (depends on 17)

The nutritional supplement of claim 17, wherein the oily carrier material enhances the uptake and bioavailability of the zeaxanthin.

### Claim 22 (depends on 17)

The nutritional supplement of claim 17, wherein the composition further includes lutein.

### Claim 23 (depends on 17)

The nutritional supplement of claim 17, wherein the capsule provides a daily dosage of the ingredients to the user that is released over a span of at least 3 hours following the oral ingestion.

### Claim 24

A nutritional supplement for eye health, comprising:
a capsule for oral ingestion that includes a composition comprising
(a) omega-3 fatty acids including docosa-hexaenoic acid (DHA) and eicosa-pentaenoic acid (EPA),
(b) at least 0.5 mg of zeaxanthin, the zeaxanthin being present in the 3R-3R′ stereoisomer form and is substantially free of meso-zeaxanthin stereoisomers,
(c) zinc in an amount that does not exceed 40 mg,
(d) vitamin E, and
(e) vitamin C in the form of ascorbic acid.
